Home › Funds › JOURNEY STRATEGIC WEALTH LLC › ABBV

JOURNEY STRATEGIC WEALTH LLC position in ABBV

ABBVIE INC · Health Care

JOURNEY STRATEGIC WEALTH LLC reported holding 24,928 shares of ABBV (ABBVIE INC) in its Q1 2026 13F filing — a position valued at US$5.4M, representing 0.13% of its reported portfolio and ranking #47 among its reported holdings. JOURNEY STRATEGIC WEALTH LLC has disclosed ABBV holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)24.93K sh
Reported value held$5.42M
Portfolio Weight0.13%
First reportedQ3 2023
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How JOURNEY STRATEGIC WEALTH LLC's ABBV position evolved

JOURNEY STRATEGIC WEALTH LLC first disclosed a stake in ABBV in Q3 2023 at 2,166 shares (US$323K). The position peaked in Q1 2026 at 24,928 shares, worth US$5.4M. Across 10 filings, JOURNEY STRATEGIC WEALTH LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 24,928 shares valued at US$5.4M — an increase of 1,849 shares quarter over quarter.. Notable position changes include a 186% increase in Q1 2024 (shares fell 5% over the following quarter), a 67% increase in Q1 2025 (shares fell 11% over the following quarter), a 42% increase in Q2 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.17K $322.93K New
Q4 2023 2.13K $329.69K Reduce
Q1 2024 6.08K $1.11M Add
Q3 2024 7.06K $1.39M Add
Q4 2024 9.73K $1.73M Add
Q1 2025 16.20K $3.39M Add
Q2 2025 23.05K $4.28M Add
Q3 2025 23.32K $5.40M Add
Q4 2025 23.08K $5.27M Reduce
Q1 2026 24.93K $5.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has JOURNEY STRATEGIC WEALTH LLC held ABBV?

JOURNEY STRATEGIC WEALTH LLC has disclosed ABBV holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

What is JOURNEY STRATEGIC WEALTH LLC's current position in ABBV?

As of Q1 2026, JOURNEY STRATEGIC WEALTH LLC holds 24.93K shares of ABBV (ABBVIE INC), valued at $5.42M, representing 0.13% of its reported portfolio and ranking #47.

Has JOURNEY STRATEGIC WEALTH LLC been buying or selling ABBV?

In the latest 13F filing (Q1 2026), JOURNEY STRATEGIC WEALTH LLC increased its position in ABBV. The position peaked in Q1 2026 at 24.93K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.